Aurora Cannabis (ACB) Non-Current Debt (2019 - 2026)
Aurora Cannabis (ACB) posted quarterly Non-Current Debt of $363144.4 for Q1 2026, down 98.92% year-over-year from $33.5 million in Q1 2025, and down 97.46% quarter-over-quarter from $14.3 million in Q4 2025.
Aurora Cannabis (ACB) Non-Current Debt (2019 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Non-Current Debt for 8 consecutive years, with $363144.4 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt fell 98.92% year-over-year to $363144.4; the TTM figure through Mar 2026 stood at $363144.4 (down 98.92% YoY), while the FY2026 annual figure was $363144.4, down 98.95% from the prior year.
- Non-Current Debt eased to $363144.4 in Q1 2026 per ACB's latest filing, from $14.3 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $156.4 million in Q2 2023 and bottomed at $96316.0 in Q1 2022.
- Historically, Non-Current Debt has averaged $53.1 million across 5 years, with a median of $35.5 million in 2023.
- Annual changes were most pronounced in 2023 — Non-Current Debt surged 155667.78% — and 2026, when it tumbled 98.92%.
- Aurora Cannabis' Non-Current Debt stood at $36.8 million in 2022, then surged by 180.7% to $103.3 million in 2023, then declined by 2.28% to $101.0 million in 2024, then tumbled by 85.85% to $14.3 million in 2025, then tumbled by 97.46% to $363144.4 in 2026.
- Business Quant data shows ACB's Non-Current Debt at $363144.4 in Q1 2026, $14.3 million in Q4 2025, and $14.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 130.00 Mn |
| 10 | Aurora Cannabis | 232.22 Mn | 159.91 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 363,144.43 |
| Dec 31, 2025 | 14.29 Mn |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 35.52 Mn |
| Mar 31, 2025 | 33.52 Mn |
| Dec 31, 2024 | 100.98 Mn |
| Sep 30, 2024 | 100.97 Mn |
| Jun 30, 2024 | 102.10 Mn |
| Mar 31, 2024 | 3.63 Mn |
| Dec 31, 2023 | 103.34 Mn |
| Sep 30, 2023 | 127.01 Mn |
| Jun 30, 2023 | 156.38 Mn |
| Mar 31, 2023 | 35.54 Mn |
| Dec 31, 2022 | 36.82 Mn |
| Sep 30, 2022 | 37.38 Mn |
| Jun 30, 2022 | 100,395.60 |
| Mar 31, 2022 | 96,316.00 |
| Dec 31, 2021 | 94,406.99 |
| Sep 30, 2021 | 89,768.25 |
| Jun 30, 2021 | 84,606.82 |